세계의 바이오해킹 시장 보고서(2025년)
Biohacking Global Market Report 2025
상품코드 : 1824517
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이오해킹 시장 규모는 향후 몇 년 동안 비약적인 성장이 예상됩니다. 2029년에는 CAGR 24.6%로 1,085억 7,000만 달러로 성장할 것입니다. 예측 기간의 성장 요인은 장수 및 노화 방지, 향정신성 약물 및 인지 기능 향상, 주류 채택, 기업 웰니스 프로그램, 규제 상황 등입니다. 예측 기간의 주요 동향으로는 장수 및 노화 방지 바이오해킹, 웨어러블 및 디바이스 바이오해킹, 향정신성 약물 및 인지 기능 향상 바이오해킹, 수면 최적화 바이오해킹, 유전자 편집 및 CRISPR 기술 등이 있습니다.

향후 5년간 24.6%의 성장률 전망은 지난번 예측보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 에스토니아나 싱가포르에서 개발된 지속형 혈당 측정기나 유전자 검사 키트의 가격을 급등시켜 자가 정량화 능력을 떨어뜨리고 예방 의료 비용을 증가시킴으로써 미국의 맞춤형 의료를 저해할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

만성질환의 확산은 가까운 장래에 바이오해킹 시장 확대를 촉진하는 중요한 요인이 될 것으로 예상됩니다. 만성질환은 장기간에 걸쳐 증상이 지속되며, 시간이 지날수록 악화되는 경우가 많습니다. 영양 섭취 최적화, 간헐적 단식, 수소 흡입 요법 및 기타 접근법과 같은 연구 방법은 암 및 기타 만성질환과 같은 질병을 퇴치할 수 있는 가능성을 보여주고 있습니다. 예를 들어, 2023년 1월 미국 국립의학도서관의 한 부서인 국립생물공학정보센터(NCBI)는 2050년까지 최소 한 가지 이상의 만성질환을 앓고 있는 50세 이상 노인이 99.5% 증가할 것이라는 경이로운 예측을 발표했습니다. 이 예측에 따르면, 2020년 7,152만 2,000명에서 1억 4,266만 명으로 급증할 것으로 보입니다. 그 결과, 이러한 만성질환 유병률의 증가는 바이오해킹 시장의 성장 궤도를 추진하는 중요한 촉매제로 인식되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Biohacking, also recognized as human augmentation or human enhancement, represents a form of self-directed biology focused on enhancing abilities, fitness, and overall wellbeing through purposeful and intentional interventions.

The primary product types encompass wearables, implants (chips), gene modification kits, smart drugs, supplements, mobile apps, and other related products. Wearables denote electronic devices worn as accessories that aid in body tracking and health monitoring. These devices consist of various components, including solutions and services, catering to multiple applications such as synthetic biology, genetic engineering, forensic science, diagnosis and treatment, and drug testing. These products and services find utilization across diverse sectors including pharmaceutical and biotechnology companies, hospitals and clinics, forensic laboratories, research and academic institutes, and other end users, contributing significantly to advancements in the field of health, science, and technology.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The biohacking report is one of a series of new reports from The Business Research Company that provides biohacking statistics, including biohacking industry global market size, regional shares, competitors with a biohacking share, detailed biohacking segments, market trends and opportunities, and any further data you may need to thrive in the biohacking industry. This biohacking market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biohacking market size has grown exponentially in recent years. It will grow from $36.61 billion in 2024 to $45.05 billion in 2025 at a compound annual growth rate (CAGR) of 23.0%. The growth in the historic period can be attributed to increased health awareness, access to information, entrepreneurial culture, and quantified self-movement.

The biohacking market size is expected to see exponential growth in the next few years. It will grow to $108.57 billion in 2029 at a compound annual growth rate (CAGR) of 24.6%. The growth in the forecast period can be attributed to longevity and anti-aging focus, nootropics and cognitive enhancement, mainstream adoption, corporate wellness programs, regulatory landscape. Major trends in the forecast period include biohacking for longevity and anti-aging, biohacking wearables and devices, nootropics and cognitive enhancement, biohacking for sleep optimization, genetic editing and CRISPR technology.

The forecast of 24.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. personalized medicine by inflating prices of continuous glucose monitors and genetic testing kits developed in Estonia and Singapore, resulting in reduced self-quantification capabilities and higher preventative health expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The escalating prevalence of chronic diseases is anticipated to be a significant driver propelling the expansion of the biohacking market in the foreseeable future. Chronic diseases encompass conditions persisting for extended periods, often deteriorating over time. Biohacking methodologies such as optimizing nutritional intake, intermittent fasting, hydrogen inhalation therapy, and other approaches have shown potential in combatting diseases such as cancer and other chronic ailments. For instance, in January 2023, the National Centre for Biotechnology Information (NCBI), a division of the US-based National Library of Medicine, projected a staggering 99.5% increase in individuals aged 50 years and older with at least one chronic illness by the year 2050. This projection foresees a surge from 71.522 million individuals in 2020 to 142.66 million individuals. Consequently, this rising prevalence of chronic diseases is identified as a key catalyst propelling the growth trajectory of the biohacking market.

The increasing demand for advanced wearable devices is expected to drive the growth of the biohacking market in the future. Wearable devices are electronic devices used on or within the human body that communicate with other devices to transmit or gather data. These devices support biohacking by providing real-time data on bodily functions, allowing users to optimize their health and performance through personalized insights and interventions. For instance, in February 2023, Parrently Apple, a blog by Apple Inc., reported that shipments of Apple smart wearables rose by 17% in 2022. Additionally, the annual shipments of smartwatches reached an increase of 50 million for the first time, representing about 60% of the global smartwatch market revenue. Therefore, the growing demand for advanced wearables is fueling the expansion of the biohacking market.

The anticipated increase in the adoption of biohacking practices by consumers is expected to drive the growth of the biohacking market. Biohacking practices, including techniques such as meditation and intermittent fasting, are gaining popularity for their reported benefits, such as increased mental focus, heightened drive and energy, and improved overall bodily efficiency, aiding in the body's ability to combat illness. For instance, the meditation market in the United States is forecasted to reach $2.08 billion by 2022, according to WebWire, a US-based online news channel. This projection underscores the growing interest and adoption of biohacking practices among consumers. As individuals seek ways to enhance their mental and physical well-being through biohacking strategies, the market is expected to expand to meet the rising demand. The adoption of biohacking practices is becoming a significant driver in propelling the growth of the biohacking market.

The biohacking market is witnessing a significant surge in the adoption of product advancements, emerging as a pivotal trend. Key players in the biohacking sector are strategically focusing on innovating new products to enhance their market positioning. An illustrative example is Velovita, a prominent US-based biohacking solutions provider, which, in January 2022, unveiled Zlem-an advanced dietary supplement bio-hacking formula designed to facilitate quality sleep and weight management. Zlem boasts a potent formulation comprising over 20 ingredients, aimed at promoting improved sleep, fat burning during nighttime rest, and the elimination of bodily impurities. The product further contributes to cultivating a balanced and healthy mental state for users each morning.

Major companies in the biohacking market are concentrating on advanced solutions, such as research-grade technology, to enhance innovation and precision in biotechnology applications. Research-grade technology refers to high-quality equipment, tools, or instruments specifically designed for scientific research, offering superior precision, accuracy, and reliability. For instance, in October 2024, SickScience Labs, Inc., a U.S.-based biotech research company focused on developing various regenerative therapies, launched the Biohacking Body-Sculpting Serum. This serum incorporates Biotech-Powered Nx35 technology and is designed to improve skin firmness, texture, elasticity, and appearance by sending precisely coded instructions to cells, triggering a specific and effective response.

Major companies operating in the biohacking market include Nootropics Depot LLC, Fitbit Inc., NOW Foods LLC, Thorne Research Inc., Primal Life Sciences Inc., OsteoStrong LLC, Jarrow Formulas Inc., Athletic Greens Inc., Wild Health Inc., Perfect Keto LLC, Mind Lab Pro LLC, Elysium Health Inc., Thync Global Inc., HVMN Inc., Thriveport LLC, Kaatsu Global Inc., Interaxon Inc., InsideTracker Inc., LifeNome Inc., Pure Encapsulations LLC

North America was the largest region in the biohacking market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the biohacking market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biohacking market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biohacking market consists of sales of TrueDark glasses, sleep systems, skin care systems, and supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biohacking Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biohacking market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for biohacking ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biohacking market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Biohacking Market Characteristics

3. Biohacking Market Trends And Strategies

4. Biohacking Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Biohacking Growth Analysis And Strategic Analysis Framework

6. Biohacking Market Segmentation

7. Biohacking Market Regional And Country Analysis

8. Asia-Pacific Biohacking Market

9. China Biohacking Market

10. India Biohacking Market

11. Japan Biohacking Market

12. Australia Biohacking Market

13. Indonesia Biohacking Market

14. South Korea Biohacking Market

15. Western Europe Biohacking Market

16. UK Biohacking Market

17. Germany Biohacking Market

18. France Biohacking Market

19. Italy Biohacking Market

20. Spain Biohacking Market

21. Eastern Europe Biohacking Market

22. Russia Biohacking Market

23. North America Biohacking Market

24. USA Biohacking Market

25. Canada Biohacking Market

26. South America Biohacking Market

27. Brazil Biohacking Market

28. Middle East Biohacking Market

29. Africa Biohacking Market

30. Biohacking Market Competitive Landscape And Company Profiles

31. Biohacking Market Other Major And Innovative Companies

32. Global Biohacking Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biohacking Market

34. Recent Developments In The Biohacking Market

35. Biohacking Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기